Effect of intracameral cefuroxime on fibrinous uveitis after pediatric cataract surgery.
OBJECTIVE
To determine whether intracameral cefuroxime reduces postoperative fibrin formation after pediatric cataract surgery.


METHODS
Children aged 3 months to 10 years with bilateral congenital or developmental cataracts who underwent surgery between February and July 2008 were eligible for inclusion in this prospective double-masked study. The same surgical technique was used in each eye. The intraocular lens was placed in either the bag or sulcus in both eyes. The same intraocular lens type was used in both eyes (polymethylmethacrylate). One eye was randomized to receive intracameral cefuroxime at the end of surgery and the fellow eye received saline. The surgeon was masked to the treatment assignment. The amount of fibrin formation in the anterior chamber of each eye was assessed by a masked grader on the fourth postoperative day.


RESULTS
Seventy eyes of 35 children were included in the study. Fibrin formation was noted on the fourth postoperative day in 14 of 70 eyes (20%), 7 in the cefuroxime group and 7 in the saline group. The mean fibrin score was 0.57 ± 1.31 in the cefuroxime group and 0.49 ± 1.07 in the saline group. There was no statistically significant difference in the amount of fibrin formation between groups (P = .857, Wilcoxon ranked signs test).


CONCLUSIONS
Intracameral cefuroxime did not significantly reduce postoperative fibrin formation in this study. Fibrin formation does not appear to be due to bacterial contamination in most cases of pediatric cataract surgery.
Gradin
Dan
D
Eye Unit, PCEA Kikuyu Hospital, Nairobi, Kenya.
Mundia
Daniel
D
D000867:Anterior Chamber / Q000187:drug effects* / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002386:Cataract / Q000151:congenital; D002387:Cataract Extraction; D002444:Cefuroxime / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D007223:Infant; D019654:Lens Implantation, Intraocular; D008297:Male; D011183:Postoperative Complications; D011446:Prospective Studies; D014606:Uveitis, Anterior / Q000378:metabolism / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D005337:Fibrin; D002444:Cefuroxime